These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 33888601)

  • 41. Lymphangioleiomyomatosis and TSC2-/- cells.
    Darling TN; Pacheco-Rodriguez G; Gorio A; Lesma E; Walker C; Moss J
    Lymphat Res Biol; 2010 Mar; 8(1):59-69. PubMed ID: 20235888
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pulmonary lymphangioleiomyomatosis (LAM)].
    Theegarten D; Hager T
    Pathologe; 2021 Feb; 42(1):35-39. PubMed ID: 33420570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Statins in lymphangioleiomyomatosis. Simvastatin and atorvastatin induce differential effects on tuberous sclerosis complex 2-null cell growth and signaling.
    Atochina-Vasserman EN; Goncharov DA; Volgina AV; Milavec M; James ML; Krymskaya VP
    Am J Respir Cell Mol Biol; 2013 Nov; 49(5):704-9. PubMed ID: 23947572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development.
    Peng H; Liu J; Sun Q; Chen R; Wang Y; Duan J; Li C; Li B; Jing Y; Chen X; Mao Q; Xu KF; Walker CL; Li J; Wang J; Zhang H
    Oncogene; 2013 Sep; 32(39):4702-11. PubMed ID: 23108404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival.
    Lesma E; Ancona S; Sirchia SM; Orpianesi E; Grande V; Colapietro P; Chiaramonte E; Di Giulio AM; Gorio A
    J Cell Mol Med; 2014 May; 18(5):766-79. PubMed ID: 24606538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tuberous sclerosis complex: a complex case.
    Powell RM; Pattison S; Moravec JC; Bhat B; Guirguis N; Markie D; Jones GT; Copedo J; Print CG; Morison IM; Gavryushkin A; Gray B; Wyeth LJ; Eccles MR; Macaulay EC
    Cold Spring Harb Mol Case Stud; 2022 Apr; 8(3):. PubMed ID: 35483879
    [TBL] [Abstract][Full Text] [Related]  

  • 47. G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling.
    Prentzell MT; Rehbein U; Cadena Sandoval M; De Meulemeester AS; Baumeister R; Brohée L; Berdel B; Bockwoldt M; Carroll B; Chowdhury SR; von Deimling A; Demetriades C; Figlia G; ; de Araujo MEG; Heberle AM; Heiland I; Holzwarth B; Huber LA; Jaworski J; Kedra M; Kern K; Kopach A; Korolchuk VI; van 't Land-Kuper I; Macias M; Nellist M; Palm W; Pusch S; Ramos Pittol JM; Reil M; Reintjes A; Reuter F; Sampson JR; Scheldeman C; Siekierska A; Stefan E; Teleman AA; Thomas LE; Torres-Quesada O; Trump S; West HD; de Witte P; Woltering S; Yordanov TE; Zmorzynska J; Opitz CA; Thedieck K
    Cell; 2021 Feb; 184(3):655-674.e27. PubMed ID: 33497611
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
    Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
    Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1.
    Somasekharan SP; El-Naggar A; Leprivier G; Cheng H; Hajee S; Grunewald TG; Zhang F; Ng T; Delattre O; Evdokimova V; Wang Y; Gleave M; Sorensen PH
    J Cell Biol; 2015 Mar; 208(7):913-29. PubMed ID: 25800057
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic characterization of disseminated cells with TSC2 loss of heterozygosity in patients with lymphangioleiomyomatosis.
    Cai X; Pacheco-Rodriguez G; Fan QY; Haughey M; Samsel L; El-Chemaly S; Wu HP; McCoy JP; Steagall WK; Lin JP; Darling TN; Moss J
    Am J Respir Crit Care Med; 2010 Dec; 182(11):1410-8. PubMed ID: 20639436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.
    Yu J; Parkhitko AA; Henske EP
    Proc Am Thorac Soc; 2010 Feb; 7(1):48-53. PubMed ID: 20160148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. TACC3-TSC2 maintains nuclear envelope structure and controls cell division.
    Gómez-Baldó L; Schmidt S; Maxwell CA; Bonifaci N; Gabaldón T; Vidalain PO; Senapedis W; Kletke A; Rosing M; Barnekow A; Rottapel R; Capellá G; Vidal M; Astrinidis A; Piekorz RP; Pujana MA
    Cell Cycle; 2010 Mar; 9(6):1143-55. PubMed ID: 20237422
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zika Virus Subverts Stress Granules To Promote and Restrict Viral Gene Expression.
    Bonenfant G; Williams N; Netzband R; Schwarz MC; Evans MJ; Pager CT
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30944179
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon beta augments tuberous sclerosis complex 2 (TSC2)-dependent inhibition of TSC2-null ELT3 and human lymphangioleiomyomatosis-derived cell proliferation.
    Goncharova EA; Goncharov DA; Chisolm A; Spaits MS; Lim PN; Cesarone G; Khavin I; Tliba O; Amrani Y; Panettieri RA; Krymskaya VP
    Mol Pharmacol; 2008 Mar; 73(3):778-88. PubMed ID: 18094073
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tsc2 disruption in mesenchymal progenitors results in tumors with vascular anomalies overexpressing
    Klover PJ; Thangapazham RL; Kato J; Wang JA; Anderson SA; Hoffmann V; Steagall WK; Li S; McCart E; Nathan N; Bernstock JD; Wilkerson MD; Dalgard CL; Moss J; Darling TN
    Elife; 2017 Jul; 6():. PubMed ID: 28695825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2-null ELT3 cells: a potential treatment for lymphangioleiomyomatosis.
    Makovski V; Haklai R; Kloog Y
    Int J Cancer; 2012 Mar; 130(6):1420-9. PubMed ID: 21500191
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen maintains myometrial tumors in a lymphangioleiomyomatosis model.
    Prizant H; Taya M; Lerman I; Light A; Sen A; Mitra S; Foster TH; Hammes SR
    Endocr Relat Cancer; 2016 Apr; 23(4):265-80. PubMed ID: 26880751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WD40 protein FBW5 promotes ubiquitination of tumor suppressor TSC2 by DDB1-CUL4-ROC1 ligase.
    Hu J; Zacharek S; He YJ; Lee H; Shumway S; Duronio RJ; Xiong Y
    Genes Dev; 2008 Apr; 22(7):866-71. PubMed ID: 18381890
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models.
    Lee N; Woodrum CL; Nobil AM; Rauktys AE; Messina MP; Dabora SL
    BMC Pharmacol; 2009 Apr; 9():8. PubMed ID: 19368729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.